All coronavirus articles – Page 4
-
BusinessEarly indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
Opinion
Follow the theory to halt Covid-19
Politicians need to show more trust in the scientific method
-
News
Pandemic risks lost generation of junior scientists as charitable funding dries-up
Survey finds coronavirus, Brexit and lack of opportunities is forcing early career researchers backed by medical charities to consider alternative professions
-
Opinion
Chemists amid coronavirus: Thomas Hartung
A biochemist at Johns Hopkins recounts how his lab pivoted to tackle Covid-19 with mini-brains, and how his love of gadgets has helped
-
Opinion
Letters: November 2020
Readers share how they’ve adapted to Covid-19, and muse on AI and the liberating impacts of chemistry
-
News
UK government faces legal action over ‘irrational’ handling of university reopenings
University union argues that expert advice was ignored, putting students and staff at risk
-
Opinion
Ethical challenge
Should researchers infect healthy people with Sars-CoV-2 to speed up vaccine testing?
-
News
First Covid-19 challenge study working with live virus planned for the UK
Pending ethics panel approval, healthy volunteers would be infected with Sars-CoV-2 to help understand disease and test vaccines
-
Webinar
LGBT+ inclusivity – Building a better chemistry culture
Join us to discuss how the chemical sciences can best support and retain LGBT+ individuals
-
Careers
Chemist may become first woman in Congress with a natural science PhD
Head of the chemistry department at Stony Brook University in New York is locked in a tight race for a seat in the House of Representatives
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
Opinion
Chemists amid coronavirus: Pierre-Edouard Danjou
A French organic chemist says Covid-19 caused a ‘big blow’ to his research, yet he published insights gained by remote teaching chemistry
-
Opinion
Blood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
Opinion
Jumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
Opinion
Chemists amid coronavirus: Paulette Vincent-Ruz
A chemistry education researcher at the University of Michigan finds Covid-19 has been a springboard for change in academia
-
Webinar
Celebrating Black History Month
Join us as we recognise and celebrate Black individuals and their contributions to the chemical sciences
-
Opinion
Chemists amid coronavirus: Philippa Ojimelukwe
A Nigerian chemist worries as her university and others in the country remain closed due to the pandemic and an academic strike
-
Business
Protein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
